[Compliance in rheumatology, from a prospective study in 32 patients].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to R Desproges-Gotteron.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Antinuclear antibodies (ANA) were demonstrated in four patients (2 male, 2 female) with reactive arthritis (RA) due to Yersinia enterocolitica (YE) and Yersinia pseudotuberculosis (YPT). Changes in ANA titres and serologic tests were not correlated. The two patients are HLA B27 positive. Polysaccharides could be partly responsible for Yersinia antigenicity. The presence of ANA in chronic forms of RA due to Yersinia warrants discussion.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Radioimmunological assays of carcino-embryonic antigen (CEA) and beta 2 microglobulin were carried out in 61 cases of malignant bone disease, including myeloma and metastases from carcinomas of the breast and prostate. CEA assays seemed to be of greater interest in mammary cancer metastases and beta 2 microglobulin assays in prostatic cancer metastases and myeloma. The correlation which appeared between CEA levels of the outcome of breast cancer metastases was of assistance in adjusting treatment. Combining CEA and beta 2 microglobulin assays would enhance their usefulness in current practice.
Treatment of giant-cell arteritis rests on corticosteroids. Three observations of Horton arteritis with initial resistance to cortisone are reported. Diagnosis was substantiated by the examination of biopsy specimens. Resistance to therapy was overcome by changing to another corticosteroid. Observations such as those reported here are very uncommon.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.